Comparable stake leader
INTRACOASTAL CAPITAL, LLC
SEC ownership of Bone Biologics Corp
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001419554.
Disclosed value leader
Don Hankey
Comparable rows
1/13
Latest evidence
28 Sep 2026
- Public ticker
- BBLG, BBLGW on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
INTRACOASTAL CAPITAL, LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
1 of 13
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
INTRACOASTAL CAPITAL, LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
28 Sep 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001419554
- Issuer location
- Burlington, MA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Bone Biologics Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
INTRACOASTAL CAPITAL, LLC
Disclosed value leader
Don Hankey
Comparable rows
1/13
Latest evidence
28 Sep 2026
13D/G
3/4/5
13F
Lead comparable stake: 10%
12 rows are not safely comparable across share classes.
13D/G row: INTRACOASTAL CAPITAL, LLC
Showing 1-8 of 13 holder rows.
Quick read
INTRACOASTAL CAPITAL, LLC leads the comparable SEC ownership view at 10%.
1 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens INTRACOASTAL CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 1
INTRACOASTAL CAPITAL, LLC
10%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
10%
Reported 13D/G
· 30 Sep 2025
|
$482,187
199,251 shares
|
+$111,397 | 30 Sep 2025 |
| Don Hankey |
3/4/5
Chairman of the Board, Director, 10%+ Owner
|
—
mixed-class rows
|
$4,289,289
7,144,395 shares
mixed-class rows
|
— | 27 Mar 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
mixed-class rows
|
$428,684
50,277 shares
mixed-class rows
|
— | 30 Jun 2026 |
| Bruce Stroever |
3/4/5
Director
|
—
denominator unverified
|
$62,642
113,896 shares
|
— | 28 Sep 2026 |
| Phillip Terry Meikle II |
3/4/5
Director
|
—
denominator unverified
|
$62,642
113,896 shares
|
— | 28 Sep 2026 |
| Robert E. Gagnon |
3/4/5
Director
|
—
denominator unverified
|
$62,642
113,896 shares
|
— | 28 Sep 2026 |
| Siddhesh Rajendra Angle |
3/4/5
Director
|
—
denominator unverified
|
$62,642
113,896 shares
|
— | 28 Sep 2026 |
| Jeff Frelick |
3/4/5
Chief Executive Officer
|
—
mixed-class rows
|
$25,882
17,028 shares
mixed-class rows
|
— | 08 Jan 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 22 Oct 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-8 of 8 reporting-owner rows connected to Bone Biologics Corp. Open a relationship link for the CIK-to-CIK filing trail.
Rows
8
Largest Forms 3/4/5 holder
Don Hankey
Net 12M change
$0
Latest report
28 Sep 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Don Hankey | Chairman of the Board, Director, 10%+ Owner | $4,289,289 | Mixed | 27 Mar 2023 | ||
| Siddhesh Rajendra Angle | Director | $62,642 | Mixed | 28 Sep 2026 | ||
| Phillip Terry Meikle II | Director | $62,642 | Mixed | 28 Sep 2026 | ||
| Bruce Stroever | Director | $62,642 | Mixed | 28 Sep 2026 | ||
| Robert E. Gagnon | Director | $62,642 | Mixed | 28 Sep 2026 | ||
| Jeff Frelick | Chief Executive Officer | $25,882 | Mixed | 08 Jan 2026 | ||
| Deina H. Walsh | Chief Financial Officer | $13,144 | Mixed | 08 Jan 2026 | ||
| Erick Lucera | Director | Mixed | 18 Sep 2023 |
Recent insider transactions for Bone Biologics Corp
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Robert E. Gagnon | BBLG | Non-Employee Stock Option | Award | 113,896 | 113,896 | 28 Sep 2026 | Direct | |||
| Siddhesh Rajendra Angle | BBLG | Non-Employee Stock Option | Award | 113,896 | 113,896 | 28 Sep 2026 | Direct | |||
| Phillip Terry Meikle II | BBLG | Non-Employee Stock Option | Award | 113,896 | 113,896 | 28 Sep 2026 | Direct | |||
| Bruce Stroever | BBLG | Non-Employee Stock Option | Award | 113,896 | 113,896 | 28 Sep 2026 | Direct | |||
| Deina H. Walsh | BBLG | Employee Stock Option | Award | 8,335 | 8,335 | 08 Jan 2026 | Direct | |||
| Jeff Frelick | BBLG | Employee Stock Option | Award | 16,668 | 16,668 | 08 Jan 2026 | Direct |
* marks a reported price that did not pass the local price check.